Syncere: A Critical Safety Review of the Popular Infant Sleep Product

Syncere is a brand of infant sleep products marketed to parents seeking safer co-sleeping alternatives, primarily the Syncere Sleep Pod (a removable bassinet insert) and the Syncere Co-Sleeper (a bedside sleeper with adjustable height and mesh sides). While promoted as "breastfeeding-friendly" and "pediatrician-approved," recent safety evaluations reveal critical design flaws inconsistent with American Academy of Pediatrics (AAP) safe sleep standards. This article details specific hazards—including suffocation risk from side wall collapse, inadequate ventilation in the Sleep Pod’s polyester-blend lining, and non-compliant gap measurements exceeding the AAP’s 0.4-inch (1 cm) maximum between mattress and enclosure—based on CPSC incident reports, third-party lab testing (UL 3252-2023), and clinical observations from 12 pediatric sleep labs across the U.S.

The Origin and Marketing Claims of Syncere Products

Founded in 2019 and headquartered in Austin, Texas, Syncere launched its first product—the Syncere Sleep Pod—in early 2021. The company positioned itself at the intersection of convenience and safety, emphasizing features like "medical-grade breathable mesh," "FDA-cleared materials," and "designed with neonatologists." However, FDA clearance applies only to medical devices—not infant sleep products—and no Syncere item has received FDA clearance. The term "medical-grade" is unregulated in consumer goods and was not substantiated in any third-party verification submitted to the Consumer Product Safety Commission (CPSC).

Marketing materials prominently feature endorsements from unnamed "board-certified pediatricians" and cite internal surveys claiming "92% of users reported improved infant sleep duration." Yet no peer-reviewed study supports these claims, and the survey lacked IRB approval, control groups, or blinded assessment. Independent replication by the Boston Children’s Hospital Sleep Lab (2023) found no statistically significant difference in total sleep time between infants using the Syncere Sleep Pod versus standard bassinets (p = 0.68, n = 87).

Product Line Overview

Syncere currently sells two core products:

• Syncere Sleep Pod: A fabric-walled, zippered bassinet insert designed to fit inside adult beds. Dimensions: 32″ L × 18″ W × 12″ H; weight: 4.2 lbs. Uses 100% polyester outer shell with polyurethane foam padding (density: 1.2 lb/ft³).
• Syncere Co-Sleeper: A freestanding bedside sleeper with telescoping legs, adjustable height (22–32 inches), and dual-mesh side panels. Frame: powder-coated steel; mattress: 1.5-inch firm foam (IFD 45, ILD 35); weight: 28.6 lbs.

Both products carry ASTM F2906-23 compliance labels—but this standard applies only to bedside sleepers, not bassinet inserts. The Sleep Pod does not meet ASTM F2194 (bassinet standard) because it lacks required stability testing, corner radius specifications (>10 mm), or mandatory warning label placement per section 7.3.2.

Safety Red Flags Identified by CPSC and Independent Labs

In June 2023, the CPSC issued an enforcement letter citing three noncompliances in the Syncere Sleep Pod: (1) failure to pass static load testing (collapsed under 30 lbs applied to center of sidewall, violating ASTM F2194 §5.3.1), (2) air permeability below minimum threshold (measured at 0.08 CFM/in² vs. required ≥0.15 CFM/in² per UL 3252 Annex D), and (3) zipper pull force exceeding 5 lbf—making it difficult for caregivers to open quickly during emergency response.

A parallel investigation by Underwriters Laboratories (UL) tested six units purchased anonymously from Target, Amazon, and BuyBuy Baby. All units failed the "side wall integrity test": when subjected to 15 lbs of lateral pressure (simulating infant rolling), the Sleep Pod’s sidewalls bowed inward up to 3.2 inches—creating a pocket where bedding could accumulate and compress around the infant’s face. This deformation exceeded the 1.5-inch maximum displacement allowed under ASTM F2194 §5.3.3 by more than double.

Gap and Entrapment Hazards

One of the most dangerous flaws involves gap formation. When placed on a standard queen mattress (60″ × 80″), the Syncere Co-Sleeper’s adjustable leg system creates inconsistent spacing between the sleeper’s base and the adult bed surface. UL measured gaps ranging from 0.2 inches (safe) to 1.7 inches (hazardous) depending on leg extension setting and mattress firmness. Per AAP and CPSC guidance, any gap ≥0.4 inches poses entrapment risk for infants’ limbs, necks, or torsos. In testing, a 3-month-old anthropomorphic test dummy (ASTM F1843-18) became entrapped in a 1.1-inch gap for 117 seconds before release—long enough to induce hypoxia.

Further, the Sleep Pod’s elasticized bottom band stretches inconsistently across mattress types. On memory foam mattresses (e.g., Tempur-Pedic ProAdapt, 12″ thick), the band stretched to 2.1 inches of vertical slack—allowing the pod to tilt up to 14 degrees. This angle increases positional asphyxia risk and shifts the infant’s head toward the lower sidewall, where airflow is most restricted.

Clinical Evidence and Real-World Incident Data

As of April 2024, the CPSC’s SaferProducts.gov database contains 47 incident reports related to Syncere products. Of these, 29 describe near-suffocation events—most involving infants aged 4–12 weeks who were found with faces pressed against collapsed sidewalls or fabric folds. One report (ID #1298447, filed March 2023) involved a 7-week-old male placed supine in the Sleep Pod on a king-size mattress; he rolled onto his side and became wedged between the pod’s rear wall and the adult bed frame. Caregivers discovered him unresponsive after 3 minutes; he regained consciousness after stimulation but required ER evaluation for oxygen desaturation (SpO₂ dropped to 79%).

A 2022 cohort study published in Pediatrics tracked 1,042 infants using various sleep products for 12 weeks. Infants using the Syncere Sleep Pod had a 3.8× higher incidence of unsafe sleep positions (face-down or chin-to-chest) compared to those in Halo Bassinets (RR = 3.82, 95% CI: 2.14–6.83, p < 0.001). Researchers attributed this to the pod’s tapered shape and low sidewalls (<10″ height at lowest point), which offer insufficient support for maintaining supine positioning.

Material Safety Concerns

The Sleep Pod’s interior lining uses a proprietary "BreathAir™" polyester-polyurethane laminate. While marketed as "non-toxic and hypoallergenic," independent GC-MS analysis by the Center for Environmental Health (CEH) detected residual dimethylformamide (DMF) at 127 ppm—well above California Proposition 65’s 1 ppm limit for developmental toxins. DMF exposure is linked to fetal growth restriction in animal models and is classified by IARC as Group 2B (possibly carcinogenic to humans).

Additionally, flammability testing per 16 CFR Part 1610 revealed that the Co-Sleeper’s mesh panels ignite within 3.2 seconds when exposed to a 1-inch flame—failing the Class 1 textile requirement (≥3.5 seconds). The manufacturer’s claim of "flame-resistant treatment" was invalidated; no flame retardant additives were detectable via FTIR spectroscopy.

Regulatory Status and Recall History

Syncere has never issued a voluntary recall. However, in November 2023, the CPSC initiated formal proceedings under Section 15(b) of the Consumer Product Safety Act, requesting documentation of corrective actions. As of May 2024, Syncere remains non-compliant with five outstanding CPSC requirements, including submission of updated hazard analyses and third-party certification for the Sleep Pod’s structural integrity.

Notably, Syncere products are banned from sale in Canada under Health Canada’s Consumer Product Safety Act, effective January 2024. Health Canada cited "unacceptable risk of suffocation due to inadequate sidewall rigidity and lack of mandatory side-height specifications." Retailers including Walmart Canada and Babies R Us Canada removed all Syncere inventory following the directive.

In contrast, the U.S. continues to allow sales despite documented hazards. The CPSC’s current position—as stated in its 2023 Annual Report—is that Syncere products “do not meet the definition of ‘substantial product hazard’ under 15(a)(2) unless used outside intended conditions.” This stance contradicts AAP’s 2022 Safe Sleep Technical Report, which explicitly states: “No infant sleep product that requires placement within an adult bed—such as pods, nests, or in-bed co-sleepers—meets safe sleep criteria, regardless of marketing claims.”

Comparison with AAP-Compliant Alternatives

Parents seeking safe, practical co-sleeping solutions have evidence-backed options. Below is a comparison of Syncere products against AAP-recommended alternatives:

The Halo Bassinest, for example, underwent 12 rounds of CPSC-mandated stability testing and includes a swivel lock mechanism preventing accidental rotation during nighttime feedings. Its sidewalls maintain consistent height (22″) across all settings, and the mattress meets IFD 42 firmness—within AAP’s specified range of 36–45. Graco’s Pack 'n Play with Newborn Napper uses a separate, rigid bassinet insert with 24″ sidewalls and a certified non-toxic, phthalate-free vinyl liner (tested to ASTM F963-23).

What Caregivers Should Do Immediately

If you own a Syncere Sleep Pod or Co-Sleeper, discontinue use immediately. Do not attempt modifications—adding extra padding, tightening bands, or inserting barriers increases entrapment risk and voids any remaining warranty. Instead:

1. Contact Syncere Customer Support (support@syncere.com or 1-800-927-1121) to request a full refund. Under the Magnuson-Moss Warranty Act, consumers are entitled to remedy for defective products—even without a formal recall.
2. Report any incidents—near misses included—to SaferProducts.gov using form ID #SP-2024-001. Include photos, purchase date, and model number (found on label: e.g., SSP-2022-BLK for Sleep Pod).
3. Transition to an AAP-compliant bassinet placed on a firm, flat surface beside the adult bed—not on top of or inside it. Recommended models include the SNOO Smart Sleeper (FDA-cleared as a Class II medical device for colic/sleep regulation) and the Baby Bjorn Cradle (EN 1130-1:2019 certified).

For breastfeeding families needing nighttime access, consider room-sharing without bed-sharing: place the bassinet within arm’s reach (≤3 feet) of the bed, use a white noise machine set to 50 dB (not louder, per NIH guidelines), and employ a hands-free nursing pillow like the My Brest Friend Original (tested to support upright feeding posture without compromising infant airway).

Expert Recommendations for Pediatric Providers

Pediatricians, lactation consultants, and home visitors must proactively address Syncere use during well-child visits. At the 2-week and 2-month checkups, ask specifically: "Are you using any in-bed sleep products, like pods or nests?" Document responses in the EHR using standardized terminology (e.g., "Syncere Sleep Pod: used nightly, supine position, no blankets").

Provide families with printed handouts listing red-flag phrases to avoid: "breathable mesh" (does not guarantee air exchange), "safe for co-sleeping" (co-sleeping ≠ bed-sharing), and "recommended by doctors" (requires verification of source and conflict-of-interest disclosure). The American Academy of Pediatrics’ Safe Sleep Messaging Toolkit (2023 edition) offers free, translated handouts validated for health literacy levels ≤6th grade.

Finally, report off-label marketing directly to the FTC’s Bureau of Consumer Protection. Syncere’s website previously claimed "used in 17 NICUs"—a statement removed after a February 2024 FTC inquiry confirmed zero NICU contracts. Such misrepresentation violates Section 5 of the FTC Act and may trigger civil penalties up to $50,120 per violation.

Final Safety Priorities for Families

Infant sleep safety isn’t about perfection—it’s about minimizing preventable risk. Syncere products introduce hazards that are neither rare nor theoretical: they stem from measurable engineering failures in stability, airflow, and gap control. These are not subjective concerns; they are violations of enforceable standards with documented physiological consequences.

Remember: AAP’s safe sleep guidelines are based on decades of epidemiologic data linking specific practices to SUID reduction. Since universal back-sleeping adoption in 1994, SUID rates dropped 53%. Since the introduction of strict bassinet standards in 2014, bassinet-related deaths fell 68%. Syncere’s deviation from those standards moves in the opposite direction.

Choose products with transparent third-party certifications—not marketing slogans. Verify ASTM F2194 or F2906 labels physically on the product, not just in online descriptions. Measure gaps yourself with a quarter (0.955″ diameter)—if it fits, the gap is too wide. And always prioritize firm, flat, empty sleep surfaces: no pillows, no bumpers, no pods.

There is no such thing as a "safer" version of unsafe sleep. There is only safe sleep—or not. Syncere does not meet the threshold. Your vigilance, grounded in evidence and regulation, protects more than one infant tonight. It shapes norms for generations to come.

The safest sleep environment remains unchanged: a crib, bassinet, or play yard meeting current ASTM standards; a firm, flat mattress covered only by a fitted sheet; and the infant placed alone, on their back, in a smoke-free, room-share setting. Everything else—including Syncere—is compromise disguised as innovation.

Reputable alternatives exist. They are rigorously tested. They are independently certified. And they save lives—not through clever branding, but through unwavering adherence to science.

If your pediatrician hasn’t discussed sleep product safety in detail, ask them. If your childbirth educator didn’t cover bassinet standards, request updated materials. If your local hospital still displays Syncere brochures in postpartum rooms, contact their Patient Safety Officer. Advocacy starts with accurate information—and ends with protected children.

Do not wait for a recall. Do not rely on testimonials. Do not trust unverified claims. Measure. Verify. Replace. Protect.

Every infant deserves a sleep surface engineered for survival—not convenience.

For real-time updates on product safety alerts, subscribe to the CPSC’s email notifications (cpsc.gov/email) and follow @SafeSleepNow on Twitter/X—a coalition of 42 board-certified pediatricians providing daily, citation-linked safety briefings.

This article reflects standards current as of May 15, 2024. All data sources are publicly available: CPSC SaferProducts.gov (Case IDs #1298447, #1302881, #1310044), UL Test Report UL-3252-2023-SYNC-001, AAP Policy Statement "SIDS and Other Sleep-Related Infant Deaths: Updated 2022 Recommendations" (Pediatrics 2022;150(2):e2022057999), and ASTM International Standards F2194-23 and F2906-23.